Hyun Bae
Net worth: 15 256 $ as of 31/07/2026
Net worth: 15 256 $ as of 31/07/2026
Dr. Hyun W.
Bae, MD, is an Independent Director at Kairos Pharma Ltd. and a Professor-Orthopaedic Surgery at Cedars-Sinai Medical Center.
He is on the Board of Directors at Kairos Pharma Ltd. Dr. Bae was previously employed as a Chief Medical Officer & Director by Prosidyan, Inc. He received his undergraduate degree from The Trustees of Columbia University in The City of New York and a doctorate degree from Yale University.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
KAIROS PHARMA, LTD. 0.23% | 31/03/2026 | 49,855 ( 0.23% ) | 15 256 $ | 31/07/2026 |
| Companies | Position | Start |
|---|---|---|
| KAIS PHARPAR | Director/Board Member | 09/09/2020 |
Cedars-Sinai Medical Center
Cedars-Sinai Medical Center Hospital/Nursing ManagementHealth Services Operates as a hospital | Corporate Officer/Principal | - |
| Companies | Position | End |
|---|---|---|
Prosidyan, Inc.
Prosidyan, Inc. Industrial SpecialtiesProcess Industries Develops fiber-based bioactive glass products | Chief Tech/Sci/R&D Officer | - |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 5 |
|---|---|
The Trustees of Columbia University in The City of New York
The Trustees of Columbia University in The City of New York Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Cedars-Sinai Medical Center
Cedars-Sinai Medical Center Hospital/Nursing ManagementHealth Services Operates as a hospital | Health Services |
Yale University
Yale University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Prosidyan, Inc.
Prosidyan, Inc. Industrial SpecialtiesProcess Industries Develops fiber-based bioactive glass products | Process Industries |
Kairos Pharma Ltd.
Kairos Pharma Ltd. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company | Health Technology |
Select your edition
All financial news and data tailored to specific country editions